Israeli antibody treatment targets most aggressive breast cancer Triple-negative breast cancer accounts for 15% to 20% of cases. JNS Staff Nov. 4, 2024
Weizmann Institute, Hebrew U, Technion among world’s top 100 schools Thirty-eight institutions on the list hail from the United States, 14 from China, eight from the United Kingdom, five from Australia, and four each from France and Germany. Noam Dvir Aug. 16, 2024
Israeli study dates Jerusalem expansion to before Assyrian exile Researchers achieved an unprecedented level of accuracy in dating First Temple period findings in the City of David. Joshua Marks May 3, 2024
Israeli researchers take step toward cure for Huntington’s disease The scientists not only slowed the progress of the disease in mouse models but even reversed some symptoms, according to the Weizmann Institute of Science. Feb. 27, 2024
Israeli algorithm offers swift and effective antibody humanization The new approach is a game-changer when adapting animal antibodies for human use. Pesach Benson Feb. 6, 2024
Israeli researchers unmask how cancer camouflages itself The research, led by professor Yifat Merbl of the Weizmann Institute of Science, sheds light on the intricate world of cellular waste processing and its role in cancer’s ability to fly under the radar of our immune defenses. Pesach Benson Sept. 27, 2023
Israeli researchers create synthetic embryos from stem cells These stem cell-based embryo-like structures, termed SEMs, developed naturally outside the womb for eight days, equivalent to day 14 in human embryonic development. Pesach Benson Sept. 7, 2023
Remarkable protein may unlock treatments for neurodegenerative diseases People with conditions such as Alzheimer’s, Parkinson’s and ALS could benefit down the road. Pesach Benson Sept. 3, 2023
Israeli academia climbs in international rankings Three blue-and-white schools make the top 100 list. Pesach Benson Aug. 15, 2023